Sort
16,300 grants matching “fatty liver disease”
Nutrient signaling at ER-Mitochondrial contacts and age-related mitochondrial dysfunction
$392,500Rajat Singh · University Of California Los Angeles · R01 · FY2023 · AG
Effect of Dietary Macronutrient Composition and Weight Loss on Liver Substrate Me
$392,500Elizabeth Jane Parks · Ut Southwestern Medical Center · RL1 · FY2007 · DK
Epigenetic Regulation of Mitochondrial Homeostasis and Energy Metabolism
$392,500Qin Yang · University Of California-Irvine · R01 · FY2021 · DK
Fatty Acid Synthesis in Specific Hypothalamic Neurons: Control of Appetite and En
$392,500Joseph L Goldstein · Ut Southwestern Medical Center · P01 · FY2007 · HL
Role of cholesteryl ester transfer protein in cellular lipid homeostasis
$392,500Richard E Morton · Cleveland Clinic Lerner Com-Cwru · R01 · FY2011 · HL
Molecular Pharmacology of Insulin Resistance in Burns
$392,499Jeevendra Martyn · Massachusetts General Hospital · R01 · FY2009 · GM
Development of liver homing PAR2 pepducins for the treatment of Hepatocellular Carcinoma
$392,485Athan Kuliopulos · Oasis Pharmaceuticals · R41 · FY2022 · CA
Perinatal Mechanisms of Detoxification
$392,435Eric F Johnson · Scripps Research Institute, The · R01 · FY2014 · HD
Metabolic stress responses and eIF2 kinase GCN2
$392,371Ronald C Wek · Indiana University Indianapolis · R01 · FY2019 · GM
Metabolic stress responses and eIF2 kinase GCN2
$392,371Ronald C Wek · Indiana University Indianapolis · R01 · FY2018 · GM
MIF in progression and treatment of ALD
$392,296Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2013 · AA
Oxysterols, Estrogen Receptor Antagonism, and Vascular Disease
$392,288Philip W Shaul · Ut Southwestern Medical Center · R01 · FY2012 · HL
Clinical Research on Non-Alcoholic Steatohepatitis
$392,240Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2004 · DK
Project 2: Nuclear Receptor Mediated Epigenetic and Immune Cell Changes in Liver Fibrosis Resulting From Toxicant Exposure
$392,212Ronald M. Evans · University Of California, San Diego · P42 · FY2021 · ES
Link of beta cell proliferation and type 2 diabetes to epigenetic regulation
$392,200Xianxin Hua · University Of Pennsylvania · R01 · FY2010 · DK
Clinical utility of leptin therapy in syndromic forms of insulin resistance.
$392,076Phillip Gorden · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK
Modulation of Acute Liver Injury
$391,942Mark J. Czaja · Albert Einstein College Of Medicine · R01 · FY2014 · DK
Modulation of Acute Liver Injury
$391,942Mark J. Czaja · Albert Einstein College Of Medicine · R01 · FY2012 · DK
Lipid transport in the intestine
$391,908Judith Storch · Rutgers, The State Univ Of N.J. · R01 · FY2017 · DK
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
$391,875Cheng Ji · University Of Southern California · R01 · FY2023 · DA
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
$391,875Cheng Ji · University Of Southern California · R01 · FY2025 · DA
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
$391,875Cheng Ji · University Of Southern California · R01 · FY2024 · DA
Identification of Novel Bioactive Lipid Metabolites for Predicting Liver-related Outcomes in Persons Co-Infected with HIV and HCV
$391,834Susanna Naggie · Duke University · R01 · FY2019 · DK
Identification of Novel Bioactive Lipid Metabolites for Predicting Liver-related Outcomes in Persons Co-Infected with HIV and HCV
$391,834Susanna Naggie · Duke University · R01 · FY2021 · DK
Identification of Novel Bioactive Lipid Metabolites for Predicting Liver-related Outcomes in Persons Co-Infected with HIV and HCV
$391,834Susanna Naggie · Duke University · R01 · FY2020 · DK